Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Pharma ad budgets to dip in 2016, but J&J, Pfizer, Roche and Novartis should still top $2B
Fierce Pharma Marketing
Mon, 06/22/15 - 12:52 pm
Tags:
Pfizer, Roche, JNJ, Novartis, drug ads
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Tags:
Teva Pharmaceutical, Momenta, Sandoz, generics, Novartis, Copaxone, MS, multiple sclerosis
Novartis exec: Pharma culture can be stumbling block to creativity
Medical Marketing and Media
Sat, 06/20/15 - 09:47 am
Tags:
creativity, innovation, Novartis, pharma industry
Biosimilar of Novartis' eye drug Lucentis launched in India
Fierce Pharma
Fri, 06/19/15 - 05:13 pm
Tags:
Novartis, India, Lucentis, biosimilars
U.S. court nixes Teva's Copaxone patent--again
Fierce Pharma
Thu, 06/18/15 - 04:00 pm
Tags:
Copaxone, patents, Teva Pharmaceuticals, generics, Momenta, Novartis, Sandoz
Novartis zeroes in on costs as blockbusters-to-be Cosentyx, Entresto rev up
Fierce Pharma
Thu, 06/18/15 - 11:10 am
Tags:
Novartis, Cosentyx, Entresto, GSK
GSK deal keeps paying off for Novartis with more positive Arzerra data
Fierce Pharma
Fri, 06/12/15 - 10:53 pm
Tags:
GSK, Novartis, Arzerra, chronic lymphocytic leukemia
This Key Amgen Drug Is Setting a Precedent
Investopedia
Tue, 06/9/15 - 09:55 am
Tags:
Amgen, Neupogen, Zarxio, Novartis, biosimilars
Top Novartis brass backs results-based drug pricing
Fierce Pharma
Mon, 06/8/15 - 09:56 pm
Tags:
Novartis, drug pricing
Digital campaigns that show pharma really can do it
Fierce Pharma Marketing
Mon, 06/8/15 - 10:44 am
Tags:
digital marketing, Novartis, Bayer, Genentech, JNJ, Janssen
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Tags:
Novartis, Neupogen, biosimilars, Zarxio, Amgen, Sandoz
Roche unchallenged at top of cancer sellers, but Celgene could fight Novartis for No. 2
Fierce Pharma
Wed, 06/3/15 - 12:26 pm
Tags:
Roche, Celgene, oncology, Novartis
Mylan deal target Perrigo bags GSK, Novartis consumer meds
Fierce Pharma
Tue, 06/2/15 - 05:03 pm
Tags:
Mylan, Perrigo, GSK, Novartis, consumer health, M&A
Roche, Novartis and Bayer snag NICE OKs
Fierce Pharma
Tue, 06/2/15 - 04:50 pm
Tags:
NICE, Roche, Novartis, Bayer, Gazyvaro, Cosentyx, Eylea
Novartis, Juno Killer T-Cells Show Promise In Another Blood Cancer
Forbes
Tue, 06/2/15 - 09:05 am
Tags:
Novartis, Juno Therapeutics, CAR-T, non-Hodgkin's lymphoma
Novartis, Celgene meds take the biggest shares of cancer drug spending
Fierce Pharma
Thu, 05/28/15 - 01:56 pm
Tags:
Novartis, Celgene, cancer
Post-swap Novartis preps cancer drug R&D road show
Fierce Biotech
Wed, 05/27/15 - 11:26 am
Tags:
Novartis, R&D, cancer, Tafinlar, Mekinist, GSK, ASCO
Novartis digs into health tech with bet on "robotic pill"
Yahoo/Reuters
Wed, 05/27/15 - 09:27 am
Tags:
Novartis, devices, Rani Therapeutics, robotic pill, R&D
Novartis' Summer Blockbuster LCZ696 Gains A Name, Skips An Advisory Panel
Forbes
Fri, 05/22/15 - 11:13 am
Tags:
Novartis, LCZ696, Entresto
Novartis' duo of COPD drugs clears Phase III on the path to an FDA decision
Fierce Biotech
Fri, 05/22/15 - 10:41 am
Tags:
Novartis, COPD, FDA, NVA237, QVA149

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.